• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

初始复合物异构化在抑制剂与二氢叶酸还原酶结合中的作用。

Role of isomerization of initial complexes in the binding of inhibitors to dihydrofolate reductase.

作者信息

Blakley R L, Cocco L

出版信息

Biochemistry. 1985 Aug 27;24(18):4772-7. doi: 10.1021/bi00339a010.

DOI:10.1021/bi00339a010
PMID:4074660
Abstract

Stopped-flow measurements of protein fluorescence quenching when methotrexate (MTX) binds to dihydrofolate reductase (isoenzyme II) of Streptococcus faecium (SFDHFR II) analyze as the sum of two differentials: a rapid binding phase and a second phase for which the observed rate constant is independent of methotrexate concentration. Analysis of variation of the ratio of the amplitude of the fast and slow phases with methotrexate concentration indicates that the second phase is an isomerization of the initial binary complex. At pH 7.3, the equilibrium constant for this isomerization is 21.9, and the forward and reverse rate constants are 0.57 and 0.026 s-1, respectively. Similar results were obtained for binding of 3-deazamethotrexate to SFDHFR II, but the forward rate constant is greater (2.9 s-1 at pH 7.3). The equilibrium constants for these isomerizations are pH independent, but the rate constants decrease as the pH is raised, probably due to deprotonation of one or more groups on the enzyme. Analysis of progress curves obtained by the development of inhibition when SFDHFR II is added last to reaction mixtures containing dihydrofolate, NADPH, and MTX gives an association constant for initial reactions of 4.3 X 10(7) M-1. Since a preliminary estimate of the association constant for the binding reaction is 7.6 X 10(5) M-1, this suggests an isomerization of the ternary complex(es) with an equilibrium constant of about 56. In addition, analysis of the progress of development of inhibition indicates a further very slow isomerization with equilibrium constant 419 and forward rate constant 2.6 min-1.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

当甲氨蝶呤(MTX)与粪肠球菌二氢叶酸还原酶(同工酶II,即SFDHFR II)结合时,采用停流法测量蛋白质荧光猝灭,结果分析为两个不同微分的总和:一个快速结合阶段和一个第二阶段,其观测速率常数与甲氨蝶呤浓度无关。分析快速和慢速阶段振幅比随甲氨蝶呤浓度的变化表明,第二阶段是初始二元复合物的异构化。在pH 7.3时,这种异构化的平衡常数为21.9,正向和反向速率常数分别为0.57和0.026 s⁻¹。对于3 - 去氮甲氨蝶呤与SFDHFR II的结合也得到了类似结果,但正向速率常数更大(在pH 7.3时为2.9 s⁻¹)。这些异构化的平衡常数与pH无关,但速率常数随pH升高而降低,这可能是由于酶上一个或多个基团的去质子化。当在含有二氢叶酸、NADPH和MTX的反应混合物中最后加入SFDHFR II时,通过抑制作用发展得到的进程曲线分析得出初始反应的缔合常数为4.3×10⁷ M⁻¹。由于结合反应缔合常数的初步估计值为7.6×10⁵ M⁻¹,这表明三元复合物的异构化平衡常数约为56。此外,抑制作用发展进程的分析表明存在另一种非常缓慢的异构化,平衡常数为419,正向速率常数为2.6 min⁻¹。(摘要截断于250字)

相似文献

1
Role of isomerization of initial complexes in the binding of inhibitors to dihydrofolate reductase.初始复合物异构化在抑制剂与二氢叶酸还原酶结合中的作用。
Biochemistry. 1985 Aug 27;24(18):4772-7. doi: 10.1021/bi00339a010.
2
Binding of methotrexate to dihydrofolate reductase and its relation to protonation of the ligand.
Biochemistry. 1985 Aug 13;24(17):4704-9. doi: 10.1021/bi00338a032.
3
Methotrexate, a high-affinity pseudosubstrate of dihydrofolate reductase.甲氨蝶呤,一种二氢叶酸还原酶的高亲和力假底物。
Biochemistry. 1979 Jun 12;18(12):2567-73. doi: 10.1021/bi00579a021.
4
Role of aspartate 27 in the binding of methotrexate to dihydrofolate reductase from Escherichia coli.
J Biol Chem. 1988 Jul 5;263(19):9187-98.
5
Kinetics of the formation and isomerization of methotrexate complexes of recombinant human dihydrofolate reductase.重组人二氢叶酸还原酶甲氨蝶呤复合物的形成及异构化动力学
J Biol Chem. 1988 Jul 25;263(21):10304-13.
6
Kinetics of methotrexate binding to dihydrofolate reductase from Neisseria gonorrhoeae.甲氨蝶呤与淋病奈瑟菌二氢叶酸还原酶结合的动力学
Biochem Pharmacol. 1984 Jul 1;33(13):2101-7. doi: 10.1016/0006-2952(84)90579-3.
7
Inhibition of dihydrofolate reductase from bacterial and vertebrate sources by folate, aminopterin, methotrexate and their 5-deaza analogues.叶酸、氨基蝶呤、甲氨蝶呤及其5-脱氮类似物对细菌和脊椎动物来源的二氢叶酸还原酶的抑制作用。
Biochem Pharmacol. 1984 Jan 15;33(2):175-9. doi: 10.1016/0006-2952(84)90472-6.
8
Kinetics of substrate, coenzyme, and inhibitor binding to Escherichia coli dihydrofolate reductase.底物、辅酶和抑制剂与大肠杆菌二氢叶酸还原酶结合的动力学
Biochemistry. 1981 Feb 17;20(4):874-9. doi: 10.1021/bi00507a034.
9
The structure of dihydrofolate reductase. I. Inactivation of bacterial dihydrofolate reductase concomitant with modification of a methionine residue at the active site.二氢叶酸还原酶的结构。I. 细菌二氢叶酸还原酶的失活与活性位点甲硫氨酸残基的修饰相伴发生。
J Biol Chem. 1975 Feb 25;250(4):1580-7.
10
Chemical mechanism of the reaction catalyzed by dihydrofolate reductase from Streptococcus faecium: pH studies and chemical modification.粪肠球菌二氢叶酸还原酶催化反应的化学机制:pH研究与化学修饰
Biochemistry. 1981 Oct 13;20(21):6024-9. doi: 10.1021/bi00524a016.

引用本文的文献

1
The Protective Effects of Nutraceutical Components in Methotrexate-Induced Toxicity Models-An Overview.营养保健品成分在甲氨蝶呤诱导的毒性模型中的保护作用——综述
Microorganisms. 2022 Oct 18;10(10):2053. doi: 10.3390/microorganisms10102053.
2
Crystal structure of 2,4-di-amino-7-(hydroxy-meth-yl)pteridin-1-ium nitrate.硝酸2,4-二氨基-7-(羟甲基)蝶啶鎓的晶体结构
Acta Crystallogr E Crystallogr Commun. 2015 May 7;71(Pt 6):o376-7. doi: 10.1107/S2056989015008397. eCollection 2015 Jun 1.